Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced ...

We’ve been invited to South Tyrol to drive the new Audi Concept C — but before we begin, let’s rewind for a moment. Audi’s transformation during the 1980s and 1990s stands as one of the most ...

In recognition of his contributions to viral vector–based therapeutics and translation, Dr. Curiel was elected a Fellow of the National Academy of Inventors. He is also a co-founder of biotech ...

Sana Biotechnology, Inc. is working on a gene therapy to cure Type 1 diabetes. Click here to find out why SANA stock is a ...

ICON-Health is uniquely positioned to become a national and global leader in research, education, outreach and public engagement that focuses on food ...

Despite the recent attention to the potential of developing and using gene therapy to treat several diseases, the therapy was ...

Lee Hwa-young, a professor of psychiatry at Cheonan Hospital, affiliated with Soonchunhyang University, recently announced ...

What is “wokeness”? You know it when you see it. It’s transgender themes in children’s cartoons. It’s anti-white racism ...

An international team led by Monash University researchers has uncovered the genetic code governing the way genetic mutations affect mRNA and result in disease.

St. Jude researchers advance CASTs, enhancing precision and activity for next-generation genome-editing therapies.

Milton Yu, PhD, is the head of automation and analytics strategy at Benchling. Prior to Benchling, he was principal product manager at AWS and a director of GTM at Microsoft. Milton received his cell ...

Women are significantly more likely than men to develop Alzheimer's disease. Earlier age at menopause is associated with a ...